Jacksonville, FL, United States of America

Mehdi Mirsaeidi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of Miami. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mehdi Mirsaeidi. Retrieved from https://idiyas.com/inventor/mehdi-mirsaeidi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mehdi Mirsaeidi: Innovator in Sarcoidosis Treatment

Introduction

Mehdi Mirsaeidi is a notable inventor based in Jacksonville, FL (US). He has made significant contributions to the field of medicine, particularly in the treatment of sarcoidosis. His innovative approach has led to the development of a unique method that utilizes GHRH antagonists.

Latest Patents

Mirsaeidi holds a patent for "GHRH antagonists for use in a method of treating sarcoidosis." This patent outlines a method that involves administering a GHRH antagonist to a mammalian subject in need of treatment. His work in this area has the potential to improve the lives of many individuals suffering from this condition.

Career Highlights

Throughout his career, Mehdi Mirsaeidi has worked with prestigious institutions, including the University of Miami and the United States Government as represented by the Department of Veterans Affairs. His experience in these organizations has enriched his research and development efforts.

Collaborations

Some of his notable coworkers include Chongxu Zhang and Andrew V Schally. Their collaborative efforts have contributed to advancements in medical research and treatment methodologies.

Conclusion

Mehdi Mirsaeidi's innovative work in the treatment of sarcoidosis through GHRH antagonists showcases his dedication to improving healthcare solutions. His contributions to the field are commendable and reflect his commitment to medical advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…